19-13207434-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_001127222.2(CACNA1A):​c.7400G>A​(p.Arg2467Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 1,519,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2467P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

2
4
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.287

Publications

1 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.271856).
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.7400G>A p.Arg2467Gln missense_variant Exon 47 of 47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.7400G>A p.Arg2467Gln missense_variant Exon 47 of 47 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.7418G>A p.Arg2473Gln missense_variant Exon 48 of 48 5 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.7406G>A p.Arg2469Gln missense_variant Exon 47 of 47 5 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.7403G>A p.Arg2468Gln missense_variant Exon 47 of 47 5 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.7403G>A p.Arg2468Gln missense_variant Exon 47 of 47 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.7367G>A p.Arg2456Gln missense_variant Exon 46 of 46 5 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.7262G>A p.Arg2421Gln missense_variant Exon 46 of 46 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636768.2 linkn.*1661G>A non_coding_transcript_exon_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*2579G>A non_coding_transcript_exon_variant Exon 47 of 47 ENSP00000519091.1
CACNA1AENST00000636389.1 linkc.*486G>A 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.*612G>A 3_prime_UTR_variant Exon 48 of 48 5 ENSP00000490617.1 O00555-2
CACNA1AENST00000635895.1 linkc.*612G>A 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.*612G>A 3_prime_UTR_variant Exon 47 of 47 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000636768.2 linkn.*1661G>A 3_prime_UTR_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*2579G>A 3_prime_UTR_variant Exon 47 of 47 ENSP00000519091.1
CACNA1AENST00000637276.1 linkc.*612G>A downstream_gene_variant 5 ENSP00000489777.1 O00555-5

Frequencies

GnomAD3 genomes
AF:
0.0000463
AC:
7
AN:
151318
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000727
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000590
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000158
AC:
2
AN:
126668
AF XY:
0.0000143
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000416
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000168
AC:
23
AN:
1368466
Hom.:
0
Cov.:
30
AF XY:
0.0000163
AC XY:
11
AN XY:
676518
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29482
American (AMR)
AF:
0.00
AC:
0
AN:
35146
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24214
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34074
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5452
European-Non Finnish (NFE)
AF:
0.0000215
AC:
23
AN:
1070000
Other (OTH)
AF:
0.00
AC:
0
AN:
56654
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000463
AC:
7
AN:
151318
Hom.:
0
Cov.:
31
AF XY:
0.0000541
AC XY:
4
AN XY:
73946
show subpopulations
African (AFR)
AF:
0.0000727
AC:
3
AN:
41278
American (AMR)
AF:
0.00
AC:
0
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5130
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10376
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000590
AC:
4
AN:
67740
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Episodic ataxia type 2 Uncertain:1
Jan 12, 2017
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1A: PP2, PP3 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Benign
-0.17
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.011
.;.;T;.;.;T;.;T;.;.
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.26
N
LIST_S2
Uncertain
0.88
D;D;D;D;D;D;.;D;D;D
M_CAP
Pathogenic
0.96
D
MetaRNN
Benign
0.27
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.47
D
PhyloP100
0.29
PrimateAI
Pathogenic
0.94
D
PROVEAN
Benign
0.20
.;N;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.29
Sift
Benign
0.28
.;T;.;.;.;.;.;.;.;.
Sift4G
Benign
0.18
T;T;.;T;.;.;.;.;.;.
Vest4
0.13
MutPred
0.34
.;Loss of MoRF binding (P = 0.0169);.;.;.;.;.;.;.;.;
MVP
0.84
MPC
0.55
ClinPred
0.24
T
GERP RS
2.9
Varity_R
0.097
gMVP
0.20
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1199275549; hg19: chr19-13318248; API